Golden Berry Juice Attenuates the Severity of Hepatorenal Injury. (1st December 2013)

• Record Type: Journal Article
• Authors: El-Gengaihi, Souad E.; Hamed, Manal A.; Khalaf-Allah, Abd El-Rahman M.; Mohammed, Mona A.
• Is Part Of: Journal of dietary supplements. Volume 10:Number 4(2013:Dec.)
• Page Start: 357
• Page End: 369
• Publication Date: 2013-12-01
• Subjects: Dietary supplements -- Periodicals; Dietary Supplements -- Periodicals; 613.205
• DOI: 10.3109/19390211.2013.830675
• Languages: English
• ISSNs: 1939-0211

Abstract

<abstract> <title>ABSTRACT</title> <p>The aim of the present work is to investigate the potential of <italic>Physalis peruviana</italic> fruits as a hepatorenal protective agent against carbon tetrachloride (CCl₄)-induced hepatic and renal fibrosis. The phytochemical screening test revealed the presence of alkaloids, free withanolides, glycowithanolides, and flavonoids. Acute toxicity study (500, 1000, and 1500 mg/kg body weight) revealed extract safety. The biological evaluation was conducted on different animal groups: control, control treated with fruit, CCl₄ group, CCl₄ treated with fruit, and CCl₄ treated with silymarin drug. The evaluation was done through measuring oxidative stress markers: malondialdehyde (MDA), superoxide dismutase (SOD), and nitric oxide (NO). Liver function indices such as aspartate and alanine aminotransferases (AST &amp; ALT), alkaline phosphatase (ALP), gamma glutamyl transferase (GGT), bilirubin, and total protein were estimated. Kidney disorder biomarkers such as creatinine, urea, and serum protein were also evaluated. Treatment improved all the investigated parameters, and the histopathological analysis confirmed our results. In conclusion, <italic>Physalis peruviana</italic> fruit succeeded to protect liver and kidney against fibrosis. Further studies are needed to identify the molecules responsible for its pharmacological application.</p> </abstract>